Discontinued Operations |
The following is a reconciliation of the loss recorded on the sale:
|
|
|
|
|
Net proceeds received from the sale of Performance Materials |
|
$ |
624,256 |
|
|
|
|
(13,161 |
) |
|
|
|
(681,973 |
) |
|
|
|
|
|
Loss on sale of Performance Materials |
|
$ |
(70,878 |
) |
|
|
|
|
| The following table summarizes the results of discontinued operations for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
342,738 |
|
|
$ |
373,686 |
|
|
$ |
386,921 |
|
|
|
|
251,917 |
|
|
|
281,566 |
|
|
|
308,679 |
|
Selling, general and administrative expenses |
|
|
33,195 |
|
|
|
37,364 |
|
|
|
37,226 |
|
Other operating expense, net |
|
|
18,289 |
|
|
|
14,462 |
|
|
|
13,023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,337 |
|
|
|
40,294 |
|
|
|
27,993 |
|
Equity in net income from affiliated companies |
|
|
(37) |
|
|
|
(12) |
|
|
|
(42) |
|
Interest expense, net (1)
|
|
|
16,210 |
|
|
|
24,453 |
|
|
|
22,965 |
|
Other (income) expense, net |
|
|
(3,481) |
|
|
|
274 |
|
|
|
474 |
|
Loss on sale of Performance Materials |
|
|
70,878 |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from discontinued operations before income tax |
|
|
(44,233) |
|
|
|
15,579 |
|
|
|
4,596 |
|
Provision (benefit) for income taxes |
|
|
58,008 |
|
|
|
1,022 |
|
|
|
(4,646) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from discontinued operations, net of tax |
|
$ |
(102,241) |
|
|
$ |
14,557 |
|
|
$ |
9,242 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| The following table summarizes the assets and liabilities of discontinued operations at December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
18,423 |
|
Accounts receivables, net |
|
|
40,484 |
|
|
|
|
143,323 |
|
Prepaid and other current assets |
|
|
4,139 |
|
|
|
|
|
|
Current assets held for sale |
|
$ |
206,369 |
|
|
|
|
|
|
Investments in affiliated companies |
|
$ |
115 |
|
Property, plant and equipment, net |
|
|
175,614 |
|
|
|
|
286,227 |
|
Other intangible assets, net |
|
|
121,113 |
|
|
|
|
8,878 |
|
|
|
|
71,697 |
|
|
|
|
|
|
Long-term assets held for sale |
|
$ |
663,644 |
|
|
|
|
|
|
|
|
|
|
|
Notes payable and current maturities of long-term debt |
|
$ |
7,766 |
|
|
|
|
30,267 |
|
Operating lease liabilities—current |
|
|
3,326 |
|
|
|
|
16,744 |
|
|
|
|
|
|
Current liabilities held for sale |
|
$ |
58,103 |
|
|
|
|
|
|
Long-term debt, excluding current portion |
|
$ |
55,972 |
|
|
|
|
8,612 |
|
Operating lease liabilities—noncurrent |
|
|
5,248 |
|
Other long-term liabilities |
|
|
17,366 |
|
|
|
|
|
|
Long-term liabilities held for sale |
|
$ |
87,198 |
|
|
|
|
|
|
|
Discontinued Operations |
The following table summarizes the results of discontinued operations related to Performance Chemicals for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
614,704 |
|
|
$ |
670,563 |
|
|
$ |
704,503 |
|
|
|
|
492,302 |
|
|
|
539,371 |
|
|
|
559,123 |
|
Selling, general and administrative expenses |
|
|
43,749 |
|
|
|
46,007 |
|
|
|
46,421 |
|
Goodwill impairment charge |
|
|
260,000 |
|
|
|
— |
|
|
|
— |
|
Other operating expense, net |
|
|
33,144 |
|
|
|
3,644 |
|
|
|
13,203 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(214,491 |
) |
|
|
81,541 |
|
|
|
85,756 |
|
Equity in net income from affiliated companies |
|
|
(172 |
) |
|
|
(213 |
) |
|
|
(251 |
) |
Interest expense, net (1)
|
|
|
16,570 |
|
|
|
20,199 |
|
|
|
18,414 |
|
|
|
|
(1,089 |
) |
|
|
(455 |
) |
|
|
(3,198 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from discontinued operations before income tax |
|
|
(229,800 |
) |
|
|
62,010 |
|
|
|
70,791 |
|
Provision for income taxes |
|
|
3,943 |
|
|
|
27,379 |
|
|
|
25,664 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from discontinued operations, net of tax |
|
$ |
(233,743 |
) |
|
$ |
34,631 |
|
|
$ |
45,127 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
At December 31, 2020, the Company’s outstanding term loans had mandatory repayment provisions, and as a result, interest expense was allocated to discontinued operations for all periods presented on the basis of the Company’s estimated debt reduction of $500,000 . See Note 29 to these consolidated financial statements for additional information regarding the Company’s sale of the Performance Chemicals business.
| The following table summarizes the assets and liabilities of discontinued operations at December 31, 2020 and 2019, respectively:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
22,153 |
|
|
$ |
17,736 |
|
Accounts receivables, net |
|
|
87,202 |
|
|
|
86,627 |
|
|
|
|
74,647 |
|
|
|
86,732 |
|
Prepaid and other current assets |
|
|
21,088 |
|
|
|
24,131 |
|
|
|
|
|
|
|
|
|
|
Current assets held for sale |
|
$ |
205,090 |
|
|
$ |
215,226 |
|
|
|
|
|
|
|
|
|
|
Investments in affiliated companies |
|
$ |
324 |
|
|
$ |
1,476 |
|
Property, plant and equipment, net |
|
|
391,524 |
|
|
|
401,595 |
|
|
|
|
326,173 |
|
|
|
583,075 |
|
Other intangible assets, net |
|
|
388,857 |
|
|
|
406,656 |
|
|
|
|
19,296 |
|
|
|
24,093 |
|
|
|
|
23,269 |
|
|
|
17,688 |
|
|
|
|
|
|
|
|
|
|
Long-term assets held for sale |
|
$ |
1,149,443 |
|
|
$ |
1,434,583 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes payable and current maturities of long-term debt |
|
$ |
— |
|
|
$ |
— |
|
|
|
|
74,728 |
|
|
|
76,482 |
|
Operating lease liabilities—current |
|
|
8,479 |
|
|
|
6,341 |
|
|
|
|
25,330 |
|
|
|
26,182 |
|
|
|
|
|
|
|
|
|
|
Current liabilities held for sale |
|
$ |
108,537 |
|
|
$ |
109,005 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
49,690 |
|
|
$ |
47,848 |
|
Operating lease liabilities—noncurrent |
|
|
10,047 |
|
|
|
16,182 |
|
Other long-term liabilities |
|
|
95,617 |
|
|
|
72,538 |
|
|
|
|
|
|
|
|
|
|
Long-term liabilities held for sale |
|
$ |
155,354 |
|
|
$ |
136,568 |
|
|
|
|
|
|
|
|
|
|
|
The Company applied the market approach to estimate the fair value of the Performance Chemicals business, which is consistent with the accounting policies described in Note 2 and the valuation techniques described in Note 15. In applying the market approach, the Company estimated the fair value using publicly traded comparable company values and applied the selected market multiples to a trailing twelve months adjusted EBITDA. As a result, the Company recorded a goodwill impairment charge of $260,000 in the fourth quarter of 2020 related to the Performance Chemicals business. |
|